Negar Mortazavi

842 total citations
22 papers, 639 citations indexed

About

Negar Mortazavi is a scholar working on Physiology, Immunology and Allergy and Pharmacology. According to data from OpenAlex, Negar Mortazavi has authored 22 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 9 papers in Immunology and Allergy and 6 papers in Pharmacology. Recurrent topics in Negar Mortazavi's work include Asthma and respiratory diseases (12 papers), Allergic Rhinitis and Sensitization (9 papers) and Drug-Induced Adverse Reactions (6 papers). Negar Mortazavi is often cited by papers focused on Asthma and respiratory diseases (12 papers), Allergic Rhinitis and Sensitization (9 papers) and Drug-Induced Adverse Reactions (6 papers). Negar Mortazavi collaborates with scholars based in Iran, United States and Sweden. Negar Mortazavi's co-authors include Hossein Esmaeilzadeh, Mohammad Madjid, Peyman Salehi, Arash Ghanbarian, Narges Sarbazi, Sima Allahverdian, Peyman Heydarian, Fereidoun Azizi, Parvin Mirmiran and Maziar Rahmani and has published in prestigious journals such as Annals of Otology Rhinology & Laryngology, BMC Infectious Diseases and Clinical Immunology.

In The Last Decade

Negar Mortazavi

18 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Negar Mortazavi Iran 8 201 197 170 92 88 22 639
Salvatore Mannino Italy 14 106 0.5× 165 0.8× 155 0.9× 159 1.7× 59 0.7× 27 786
Genevieve Gabb Australia 9 82 0.4× 61 0.3× 49 0.3× 53 0.6× 34 0.4× 28 577
Mary Naglak United States 9 132 0.7× 237 1.2× 212 1.2× 36 0.4× 74 0.8× 24 611
Tzippora Shochat Israel 9 365 1.8× 209 1.1× 71 0.4× 150 1.6× 21 0.2× 14 750
Mark Holdbrook United States 14 337 1.7× 121 0.6× 289 1.7× 108 1.2× 56 0.6× 28 909
Dana Troxclair United States 11 113 0.6× 46 0.2× 123 0.7× 102 1.1× 99 1.1× 17 714
Aristofanis Gikas Greece 14 110 0.5× 48 0.2× 48 0.3× 164 1.8× 60 0.7× 22 592
Surujpal Teelucksingh Trinidad and Tobago 15 187 0.9× 56 0.3× 129 0.8× 44 0.5× 35 0.4× 71 764
B Costa Spain 15 489 2.4× 144 0.7× 176 1.0× 180 2.0× 47 0.5× 58 835
Carmen P. Escalante United States 14 31 0.2× 59 0.3× 119 0.7× 71 0.8× 60 0.7× 25 942

Countries citing papers authored by Negar Mortazavi

Since Specialization
Citations

This map shows the geographic impact of Negar Mortazavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Negar Mortazavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Negar Mortazavi more than expected).

Fields of papers citing papers by Negar Mortazavi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Negar Mortazavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Negar Mortazavi. The network helps show where Negar Mortazavi may publish in the future.

Co-authorship network of co-authors of Negar Mortazavi

This figure shows the co-authorship network connecting the top 25 collaborators of Negar Mortazavi. A scholar is included among the top collaborators of Negar Mortazavi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Negar Mortazavi. Negar Mortazavi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahmoudi, Laleh, et al.. (2025). Prevalence of Depression in Elderly Patients With Osteoarthritis: A Cross‐Sectional Study. Musculoskeletal Care. 23(3). e70179–e70179.
2.
Esmaeilzadeh, Hossein, et al.. (2024). Risk Factors and Comorbidities of Recurrent Nasal Polyposis. Iranian Journal of Allergy Asthma and Immunology. 23(5). 502–513.
3.
Esmaeilzadeh, Hossein, et al.. (2024). Tic disorder in allergic rhinitis children and adolescents: a case-control study. BMC Pediatrics. 24(1). 20–20.
4.
Esmaeilzadeh, Hossein, et al.. (2023). Face mask correlation with allergic rhinitis symptoms severity during COVID‐19 pandemic: A cross‐sectional study. Health Science Reports. 6(4). e1226–e1226. 3 indexed citations
5.
Esmaeilzadeh, Hossein, et al.. (2023). Assessment of the first presentations of common variable immunodeficiency in a large cohort of patients. BMC Immunology. 24(1). 9–9. 4 indexed citations
6.
Esmaeilzadeh, Hossein, et al.. (2022). Asthma and COPD Overlap Syndrome (ACOS): Risk Factors and Contributing Factors. Medical Journal of the Islamic Republic of Iran. 36. 151–151. 1 indexed citations
7.
Esmaeilzadeh, Hossein, et al.. (2022). Investigating the association of atopy and aeroallergensensitization and chronic spontaneous urticaria. Advances in Dermatology and Allergology. 39(1). 121–125. 3 indexed citations
8.
Esmaeilzadeh, Hossein, et al.. (2022). A Review of Aspirin-exacerbated Respiratory Diseases and Immunological Efficacy of Aspirin Desensitization. Iranian Journal of Allergy Asthma and Immunology. 21(5). 512–523. 1 indexed citations
9.
Esmaeilzadeh, Hossein, et al.. (2022). Persistent cough and asthma-like symptoms post COVID-19 hospitalization in children. BMC Infectious Diseases. 22(1). 244–244. 23 indexed citations
10.
Omer, Abdullah Khalid, et al.. (2022). A Review on the Antiviral Activity of Functional Foods Against COVID-19 and Viral Respiratory Tract Infections. International Journal of General Medicine. Volume 15. 4817–4835. 9 indexed citations
11.
Esmaeilzadeh, Hossein, et al.. (2021). Can eosinophilia and neutrophil–lymphocyte ratio predict hospitalization in asthma exacerbation?. Allergy Asthma and Clinical Immunology. 17(1). 16–16. 14 indexed citations
12.
Esmaeilzadeh, Hossein, Negar Mortazavi, Alireza Salehi, et al.. (2021). Effect of COVID-19 on Kawasaki Disease: Decrease Age of Onset and Increase Skin Manifestation. BMC Pediatrics. 21(1). 571–571. 5 indexed citations
13.
Ghasemiyeh, Parisa, Negar Mortazavi, Iman Karimzadeh, et al.. (2021). Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications.. PubMed. 20(3). 66–77. 6 indexed citations
14.
Esmaeilzadeh, Hossein, et al.. (2021). Aspirin Exacerbated Respiratory Disease and Nasal Polyp Phenotyping.. PubMed. 20(4). 21–28. 1 indexed citations
15.
Mortazavi, Negar, et al.. (2017). Clinical and Immunological Efficacy of Aspirin Desensitization in Nasal Polyp Patients with Aspirin-Exacerbated Respiratory Disease.. PubMed. 16(4). 1639–1647. 32 indexed citations
16.
Esmaeilzadeh, Hossein, Mohammad Nabavi, Zahra Aryan, et al.. (2015). Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial. Clinical Immunology. 160(2). 349–357. 61 indexed citations
17.
Esmaeilzadeh, Hossein, Mohammad Nabavi, Ali Akbar Amirzargar, et al.. (2015). HLA-DRB and HLA-DQ Genetic Variability in Patients with Aspirin-Exacerbated Respiratory Disease. American Journal of Rhinology and Allergy. 29(3). e63–e69. 30 indexed citations
18.
Esmaeilzadeh, Hossein, Mohammad Nabavi, Saba Arshi, et al.. (2014). Aspirin hypersensitivity in Iranian patients with chronic rhinosinusitis and nasal polyposis: prevalence and comorbid factors. Clinical and Translational Allergy. 4(S3). 1 indexed citations
19.
Nabavi, Mohammad, Hossein Esmaeilzadeh, Saba Arshi, et al.. (2014). Aspirin Hypersensitivity in Patients with Chronic Rhinosinusitis and Nasal Polyposis: Frequency and Contributing Factors. American Journal of Rhinology and Allergy. 28(3). 239–243. 22 indexed citations
20.
Azizi, Fereidoun, Maziar Rahmani, Habib Emami, et al.. (2002). Cardiovascular risk factors in an Iranian urban population: Tehran Lipid and Glucose Study (Phase 1). Sozial- und Präventivmedizin. 47(6). 408–426. 422 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salvatore Mannino Breakdown of academic impact, for papers by Genevieve Gabb Breakdown of academic impact, for papers by Mary Naglak Breakdown of academic impact, for papers by Tzippora Shochat Breakdown of academic impact, for papers by Mark Holdbrook Breakdown of academic impact, for papers by Dana Troxclair Breakdown of academic impact, for papers by Aristofanis Gikas Breakdown of academic impact, for papers by Surujpal Teelucksingh Breakdown of academic impact, for papers by B Costa Breakdown of academic impact, for papers by Carmen P. Escalante
Rankless by CCL
2026